Literature DB >> 3930684

Crohn's disease activity: assessment by factor VIII coagulation proteins.

S Zielen, S W Bender, W Kreuz, H G Posselt, E Solem, I Scharrer.   

Abstract

Twenty-eight patients (mean age 13.5 years) with proven Crohn's disease were examined for factor VIII coagulation activity (VIII:C), factor VIII-related antigen (VIII R:Ag), and factor VIII-related ristocetin cofactor activity (VIII R:RCF). The factor VIII coagulation proteins were correlated with disease activity index according to van Hees and were compared with inflammatory parameters such as erythrocyte sedimentation rate, c-reactive protein, and orosomucoid. Among the factor VIII proteins, factor VIII-related protein (VIII R:Ag) correlates best with van Hees disease activity index, orosomucoid, c-reactive protein, and erythrocyte sedimentation rate (p less than 0.001 for all parameters). Since acute phase proteins are produced by liver cells, whereas VIII R:Ag is synthesized by endothelial cells, we postulate that this coagulation factor is highly sensitive in reflecting the inflammatory process in the intestine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930684

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  3 in total

1.  Predicting relapses of Crohn's disease. Clouds in the crystal ball.

Authors:  D B Sachar
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

2.  High Factor VIII Levels and Recurrent Thromboembolism in Patients with and without Inflammatory Bowel Disease: A Retrospective Comparative Study.

Authors:  G E Eagle; Sam Schulman
Journal:  TH Open       Date:  2022-06-13

3.  Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases.

Authors:  A M Sawyerr; M S Smith; A Hall; M Hudson; C R Hay; A J Wakefield; M G Brook; H Tomura; R E Pounder
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.